USCIS Issues Clarification on H-1B Proclamation

Oct 23, 2025 | Human Resources Services

October 22, 2025 Update on the $100,000 H-1B Fee

On October 20, 2025, USCIS issued further clarification on the Proclamation on Restriction on Entry of Certain Nonimmigrant Workers that was issued on September 19, 2025.

In a nutshell, who is NOT subject to the $100,000 fee?

The $100,000 fee does not apply to:

  • Foreign nationals who have a currently valid H-1B visa foil
  • Foreign nationals whose H-1B petitions were filed before September 21, 2025
  • Foreign nationals who receive an approval of their H-1B petition requesting a Change of Status, Amendment, Extension of Stay, or Change of Employer. Such foreign nationals will not become subject to the fee if they leave the U.S. and apply for a visa foil based on the approved petition.

For further clarification on the proclamation, view WR Immigration’s H-1B Proclamation Guidance handout below, where we provide an in-depth analysis on the H-1B fee, eligibility, and payment options.

For case-specific questions and/or further guidance on the $100,000 H-1B fee that keeps evolving, please contact your WR Immigration attorney.

Subscribe to the WR Immigration Newsletters

Start the RFP Process

Join the Corporate Benchmarking Roundtable

Request an Attorney Consultation

Related Posts:

Form I-9: Out with the Old, In with the New

By Kimberley Best Robidoux Are you ready for November 1? If you’re wondering why we’re asking, it’s because November 1 is the day that employers may use ONLY the new edition of the Form I-9 (dated 08/01/2023). If you didn’t remember, never fear. At WR Immigration, we are I-9 geeks...

HR’s Crucial Role in Life Sciences IPOs

Much attention has been given to venture investments in New England life sciences companies. Private funding is creating an incredible lift for lab space, office space, hiring, and overall innovation. IPOs, however, deserve as much recognition. Larger and fast-growing companies are heading for the Street, with nearly 50 U.S. biotech...